SKI Market

Indian Indices

Nifty

24,677.80 -30.60
(-0.12%)

Sensex

81,709.12 -56.74
( -0.07%)

Bank Nifty

53,509.50 -94.05
( -0.18%)

Nifty IT

44,716.05 -90.35
( -0.20%)

Global Indices

Nasdaq

19,859.77 159.05
(0.81%)

Dow Jones

44,642.52 -123.19
(-0.28%)

Hang Seng

19,865.85 305.41
(1.56%)

Nikkei 225

39,091.17 -304.43
(-0.77%)

Forex

USD-INR

84.71 0.00
(0.00%)

EUR-INR

89.34 0.33
(0.37%)

GBP-INR

107.84 0.40
(0.37%)

JPY-INR

0.56 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

570.1532213

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

12.5

290.53

EPS(TTM)

Face Value()

Div & Yield %

65.12

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	83.66	78.12	75.61	96.57	70.58	91.08
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	83.66	78.12	75.61	96.57	70.58	91.08
Other Income	6.63	6.93	5.77	3.79	5.89	5.16
Stock Adjustments	3.13	-3.64	-0.71	0.05	2.94	-0.01
Total Income	93.42	81.41	80.67	100.41	79.41	96.23
EXPENDITURE :
Raw Materials	40.38	42.11	39.01	50.11	42.97	50.76
Power & Fuel Cost	3.05	3.10	2.55	2.05	1.82	1.85
Employee Cost	11.20	11.13	11.23	10.18	9.70	9.84
Other Manufacturing Expenses	3.96	4.55	4.01	5.81	4.64	7.27
Selling & Administrative Expenses	8.39	5.98	9.61	9.32	6.45	6.53
Miscellaneous Expenses	3.74	3.80	0.28	3.29	2.52	2.40
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	70.72	70.68	66.69	80.76	68.10	78.65
Operating Profit	22.71	10.75	13.99	19.64	11.31	17.58
Interest	0.00	0.34	0.14	0.04	0.19	0.17
Gross Profit	22.71	10.41	13.85	19.60	11.12	17.41
Depreciation	1.98	2.18	1.99	1.98	2.01	1.90
Profit Before Tax	20.73	8.23	11.86	17.62	9.11	15.51
Tax	4.91	1.82	2.75	4.50	2.50	5.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.03	-0.04	0.06	-0.44	-0.51	0.29
Reported Net Profit	15.79	6.45	9.05	13.55	7.13	10.22
Extraordinary Items	-0.12	0.03	0.73	0.01	0.00	0.00
Adjusted Net Profit	15.91	6.42	8.32	13.54	7.13	10.22
Adjustment below Net Profit	0.00	0.00	0.00	0.00	-4.37	-11.92
P & L Balance brought forward	131.67	125.23	116.18	102.63	105.99	108.56
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.86	0.86
P & L Balance carried down	147.46	131.67	125.23	116.18	107.89	105.99
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	20.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	2.00
Earnings Per Share-Unit Curr	44.19	18.04	25.32	37.94	19.96	28.60
Earnings Per Share(Adj)-Unit Curr	44.19	18.04	25.32	37.94	19.96	28.60
Book Value-Unit Curr	496.83	433.29	436.81	382.48	323.77	318.45
Book Value(Adj)-Unit Curr	496.83	433.29	436.81	382.48	323.77	318.45

24,677.80 -30.60 (-0.12%)

81,709.12 -56.74 ( -0.07%)

53,509.50 -94.05 ( -0.18%)

44,716.05 -90.35 ( -0.20%)

19,859.77 159.05 (0.81%)

44,642.52 -123.19 (-0.28%)

19,865.85 305.41 (1.56%)

39,091.17 -304.43 (-0.77%)

84.71 0.00 (0.00%)

89.34 0.33 (0.37%)

107.84 0.40 (0.37%)

0.56 0.00 (0.12%)